China SXT Pharmaceuticals Inc (SXTC) — Financial Flexibility Index
China SXT Pharmaceuticals Inc (SXTC) has a Financial Flexibility Index of -0.08x as of June 2025. Free cash flow of $-493.06K (operating CF $-494.08K minus capex $1.01K) represents 0% of total liabilities ($6.22 Million). Also explore SXTC shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
China SXT Pharmaceuticals Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for China SXT Pharmaceuticals Inc across 10 annual periods. Check China SXT Pharmaceuticals Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for China SXT Pharmaceuticals Inc (2016–2025)
Year-by-year free cash flow to debt coverage for China SXT Pharmaceuticals Inc. For the full company profile including market capitalisation, see China SXT Pharmaceuticals Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.38x | $-2.34 Million | $-2.35 Million | $6.22 Million | ▼ -80.3% |
| 2024 | -0.21x | $-1.92 Million | $-1.93 Million | $9.20 Million | ▼ -30720.4% |
| 2023 | 0.00x | $-10.07K | $-80.76K | $14.86 Million | ▼ -103.5% |
| 2022 | 0.02x | $330.78K | $268.29K | $17.12 Million | ▲ +129.3% |
| 2021 | -0.07x | $-1.22 Million | $-1.32 Million | $18.59 Million | ▼ -160.4% |
| 2020 | 0.11x | $1.34 Million | $934.25K | $12.30 Million | ▼ -18.3% |
| 2019 | 0.13x | $849.28K | $239.19K | $6.36 Million | ▼ -80.4% |
| 2018 | 0.68x | $2.97 Million | $1.92 Million | $4.37 Million | ▲ +407.3% |
| 2017 | 0.13x | $479.35K | $293.04K | $3.58 Million | ▲ +166.2% |
| 2016 | 0.05x | $279.46K | $182.47K | $5.55 Million | — |